Panbela Therapeutics Inc   (PBLA)

As one of many businesses, the PBLA published as well the fourth quarter of 2022 effort

company delivered fourth quarter of 2022 operating loss of $-5.18 millions

Published Mar 22 2023
Goran Soko / CSIMarket.com Contributer

pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons The stockholders did not anticipate any modifications at the business during the the October to December 31 2022 reporting cycle at the company. But, investors monitor PBLAs' operating deficit which was at $-5.18 millions, during the matching time.

The operating deficit has depleted from $-3.326 millions, from the fourth quarter of 2021. But more crucially, the investors are speculating, if the Major Pharmaceutical Preparations company's will begin to report the revenue.

The CFO is on the quest for distinct financial plans, consecutively to obtain constant service. Over the same period the deficit, which the company has dealt with during the arising cycle, has extended to $-4.735 millions, from $-3.550 millions, from the comparable reporting period a year ago.

Panbela Therapeutics Inc announced loss of $-34.93 millions and Revenues of $0.00 millions in the fiscal year 2022.

Net loss per share has widen to $-67.91 from $-0.87 in prior fiscal year, while by 0 % from $0.00 millions a year prior.

Panbela Therapeutics Inc is expected to report next financial earnings on May 11, 2023.

Panbela Therapeutics Inc's Receivables Turnover Ratio

Panbela Therapeutics Inc's Receivables Turnover Ratio


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071